Updates on Clinical Trials Evaluating the Regenerative Potential of Allogenic Mesenchymal Stem Cells in COVID-19

Scientists evaluate the safety and efficacy outcomes of the most recent, placebo-controlled Phase I/II clinical studies that enrolled a larger number of patients, in order to provide a statistically relevant and comprehensive understanding of MSC’s therapeutic potential in severe COVID-19 patients.